These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3811577)

  • 1. [Natural killer cell activity in patients with focal scleroderma].
    Suchkova TN; Cheknev SB
    Vestn Dermatol Venerol; 1986; (10):13-7. PubMed ID: 3811577
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunological parallels in patients with focal scleroderma].
    Suchkova TN; Kurmanova LV; Ermolin GA; Suchkov SV
    Vestn Dermatol Venerol; 1989; (2):13-9. PubMed ID: 2786297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The connection between the decomposition of mature collagen and the level of natural cytotoxicity in patients with focal scleroderma].
    Prozorovskaia NN; Suchkova TN; Kozlov EA; Suchkov SV; Prokhorova TA; Del'vig AA
    Vopr Med Khim; 1991; 37(2):54-6. PubMed ID: 1897196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible role of natural cytotoxicity in impairment of collagen catabolism in focal scleroderma].
    Prozorovskaia NN; Suchkova TN; Suchkov SV; Del'vig AA
    Vopr Med Khim; 1988; 34(1):95-100. PubMed ID: 3369133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunocorrecting therapy in focal scleroderma].
    Suchkova TN; Prozorovskaia NN; Suchkov SV; Del'vig AA
    Vestn Dermatol Venerol; 1987; (9):8-14. PubMed ID: 3424992
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunohistochemical characterization of the cellular infiltrate in localized scleroderma.
    Xie Y; Zhang X; Wakasugi S; Makino T; Inoue Y; Ihn H
    Int J Dermatol; 2008 May; 47(5):438-42. PubMed ID: 18412858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotyping of chimeric cells in localized scleroderma.
    McNallan KT; Aponte C; el-Azhary R; Mason T; Nelson AM; Paat JJ; Crowson CS; Reed AM
    Rheumatology (Oxford); 2007 Mar; 46(3):398-402. PubMed ID: 17085771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disorders of T-cell immunity in patients with focal scleroderma].
    Suchkova TN
    Vestn Dermatol Venerol; 1986; (11):12-6. PubMed ID: 3493599
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.
    Ginsburg CH; Dambrauskas JT; Ault KA; Falchuk ZM
    Gastroenterology; 1983 Oct; 85(4):846-51. PubMed ID: 6884709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative evaluation of T-, B- and 0-lymphocyte populations in focal scleroderma].
    Fedorova EG
    Vestn Dermatol Venerol; 1980 Jun; (6):17-9. PubMed ID: 6967244
    [No Abstract]   [Full Text] [Related]  

  • 11. [HL-A antigens in focal scleroderma and Pasini-Pierini syndrome].
    Dolbin AG; Fedorova EG; Zaretskaia IuM
    Vestn Dermatol Venerol; 1978 Jul; (7):16-9. PubMed ID: 695896
    [No Abstract]   [Full Text] [Related]  

  • 12. [The cyclic nucleotide system of patients with focal scleroderma].
    Suchkova TN; Sharova NM; Cheknev SB; Suchkov SV
    Vestn Dermatol Venerol; 1990; (3):35-8. PubMed ID: 2368491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the Signature Immune Phenotypes Present in Pediatric Localized Scleroderma.
    Mirizio E; Marathi A; Hershey N; Ross C; Schollaert K; Salgado C; Reyes-Mugica M; Torok KS
    J Invest Dermatol; 2019 Mar; 139(3):715-718. PubMed ID: 30616925
    [No Abstract]   [Full Text] [Related]  

  • 14. [Natural killer cell activity in multiple sclerosis patients].
    Pál E; Varjú G; Vécsei L; Szekeres J; Pálffy G
    Orv Hetil; 1997 Dec; 138(50):3167-70. PubMed ID: 9446081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract].
    Bruns CJ; Schäfer H; Wolfgarten B; Engert A
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():146-9. PubMed ID: 9101816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunofluorescent studies in patients with scleroderma and in their families].
    Szczepański A
    Przegl Dermatol; 1972; 59(6):727-32. PubMed ID: 4566145
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vivo study of cellular immunity in patients with scleroderma].
    Olszewska Z; Arkuszewska C; Płuzańska A
    Przegl Dermatol; 1984; 71(4):317-25. PubMed ID: 6515028
    [No Abstract]   [Full Text] [Related]  

  • 19. [Regulation of natural killer activity by adherent cells in synovial rheumatoid medium].
    Combe B; Pope R; Darnell B; Sany J; Talal N
    Rev Rhum Mal Osteoartic; 1985 Jun; 52(6):385-90. PubMed ID: 3876589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased natural killer cell activity in patients with zinc deficiency with sickle cell disease.
    Tapazoglou E; Prasad AS; Hill G; Brewer GJ; Kaplan J
    J Lab Clin Med; 1985 Jan; 105(1):19-22. PubMed ID: 3968462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.